Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
GlaxoSmithKline
|
| gptkbp:acquisitionYear |
2012
|
| gptkbp:focus |
drug development
human genomics |
| gptkbp:foundedBy |
gptkb:William_A._Haseltine
|
| gptkbp:foundedYear |
1992
|
| gptkbp:headquartersLocation |
gptkb:Rockville,_Maryland,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableEmployee |
gptkb:William_A._Haseltine
|
| gptkbp:notableProduct |
gptkb:Raxibacumab
gptkb:Benlysta Albuferon |
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:HGSI
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:HGSI
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Human Genome Sciences, Inc.
|